About Exalenz Bioscience
Exalenz Bioscience is a Healthcare company based in Modi'in-maccabim-re'ut (Israel) founded in 2006, and was acquired by Meridian Bioscience in February 2020. Breath gas analysis to detect H pylori infection and diagnose Gastric and hepatocellular cancer. Its focus areas include Life Sciences, Gastroenterology, Medical Devices and Screening Devices. Its competitors include GI View and OutSense Diagnostics; 1 of its 2 listed competitors has raised funding.
Company details
Exalenz Bioscience was founded in 2006 and focuses on medical diagnostics in the gastrointestinal and liver disorder sector. Non-invasive breath analysis systems are developed and commercialized by the company to identify H. pylori bacteria, a key factor in peptic ulcers and gastric cancer risks. Hepatocellular cancer monitoring is also enabled by the technology. Regulatory approvals have been obtained in the USA, Europe, and China, with tests completed in 10-15 minutes.
- Headquarters Modi'in-maccabim-re'ut, Israel
- Stage Acquired
- SectorsHealthcare
- Website exalenz.com
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by Meridian Bioscience (Feb 2020)
- Investors
- Acquired byMeridian Bioscience
(Feb 2020)
Apps and channels of Exalenz Bioscience
its YouTube channel Meridian Bioscience has 438 subscribers and 30 videos.
Videos from Exalenz Bioscience
The most watched videos on Exalenz Bioscience's YouTube channel, Meridian Bioscience (438 subscribers). Click a video to play it here.
More on Meridian Bioscience.
Investors in Exalenz Bioscience
Exalenz Bioscience has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Meridian Bioscience.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Molecular diagnostic device and kits | 1976 | meridianbioscience.com | Ohio, United States |
Investor details for Exalenz Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Exalenz Bioscience
2 dated milestones of Exalenz Bioscience across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Exalenz Bioscience is founded.
- Exit Acquired by Meridian Bioscience.
Competitors of Exalenz Bioscience
Exalenz Bioscience has 2 listed competitors in our database, 1 of them funded. They include GI View and OutSense Diagnostics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| giview.com | 2004 | Ramat Gan, Israel | $10M | Devices for GI disorder diagnosis and treatment are developed. | ||
| outsensediagnostics.com | 2016 | Or Yehuda, Israel | AI-powered IoT devices for waste-based health diagnostics are provided. |
Detailed competitors of Exalenz Bioscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Exalenz Bioscience
Complete news archive for Exalenz Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Exalenz Bioscience
Exalenz Bioscience was founded in 2006.
Exalenz Bioscience is headquartered in Modi'in-maccabim-re'ut, Israel. It is registered at Modi'in-maccabim-re'ut, Central District, Israel.
Exalenz Bioscience was founded in 2006 and focuses on medical diagnostics in the gastrointestinal and liver disorder sector. Non-invasive breath analysis systems are developed and commercialized by the company to identify H. pylori bacteria, a key factor in peptic ulcers and gastric cancer risks. Hepatocellular cancer monitoring is also enabled by the technology. Regulatory approvals have been obtained in the USA, Europe, and China, with tests completed in 10-15 minutes.
Exalenz Bioscience's top competitors include OutSense Diagnostics and GI View.
Exalenz Bioscience has 1 investor. Key investors include Meridian Bioscience.
Yes. Exalenz Bioscience was acquired by Meridian Bioscience in February 2020.